Cargando…
Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
BACKGROUND: The Xpert® MTB/RIF (XP) has a higher sensitivity than sputum smear microscopy (70% versus 35%) for TB diagnosis and has been endorsed by the WHO for TB high burden countries to increase case finding among HIV co-infected presumptive TB patients. Its impact on the diagnosis of smear-negat...
Autores principales: | Hermans, Sabine M., Babirye, Juliet A., Mbabazi, Olive, Kakooza, Francis, Colebunders, Robert, Castelnuovo, Barbara, Sekaggya-Wiltshire, Christine, Parkes-Ratanshi, Rosalind, Manabe, Yukari C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473987/ https://www.ncbi.nlm.nih.gov/pubmed/28622763 http://dx.doi.org/10.1186/s12879-017-2534-2 |
Ejemplares similares
-
Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022) -
Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018) -
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
por: Lombardi, Giulia, et al.
Publicado: (2017) -
Xpert(®) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis
por: Zawedde-Muyanja, S., et al.
Publicado: (2018) -
Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal
por: Khadka, Priyatam, et al.
Publicado: (2019)